The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year follow-up study.
Nicole Jannelle Look Hong
No relevant relationships to disclose
Francis J Hornicek
No relevant relationships to disclose
David C. Harmon
No relevant relationships to disclose
Edwin Choy
No relevant relationships to disclose
Yen-Lin Chen
No relevant relationships to disclose
Sam S. Yoon
No relevant relationships to disclose
G. Petur Nielsen
No relevant relationships to disclose
Jackie Szymonifka
No relevant relationships to disclose
Beow Yong Yeap
No relevant relationships to disclose
Thomas F. DeLaney
No relevant relationships to disclose
John Thomas Mullen
No relevant relationships to disclose